# Vaxcyte’s stock jumps as pneumococcal vaccine holds its own against Pfizer's, Merck’s shots

> **Newsylist Open Intelligence Dossier** · First detected: 2026-10-05 19:29 UTC · Category: Business · Sources: 7 · Current Velocity: 4.63

## Intelligence Brief
"Vaxcyte’s stock jumps as pneumococcal vaccine holds its own against Pfizer's, Merck’s shots" developed substantial multi-source reporting across the Business sector, tracked across 7 distinct newsrooms by Newsylist.


Key reporting was led by Yahoo Finance, tikr.com, statnews.com and Barron's. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### What drove coverage for Vaxcyte’s stock jumps as pneumococcal vaccine holds its own against Pfizer'?
Coverage spiked when 7 independent newsrooms published 7 verified reports during this coverage cycle.

### How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.

## Key People, Organizations & Locations
Merck, Pfizer, Vaxcyte

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Yahoo Finance | NVAX Stock Outruns Moderna As Vaxcyte’s Shot Clears A Late-Stage Test | 2026-10-05 12:41 | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxOX0VscGpydlNCYkVpaFlweDNuRWZBM0NoRlV3XzFPbExHY0dRY0x6UG5qeWNYdHpmaVo4Y2hLdm05MUt6LVFLMFFwYXVGSTlFY3FqdUpYNGtuUlNlRWRLU3E3bjlRUXNaM1o3MEhFa3VNWHFpZk5JUmItZk93aW80LUMzbXUxZ1EydkR4bU0wZXhxaGhIWG5OTzRJaw?oc=5) |
| tikr.com | Vaxcyte Soars 36% on Phase 3 Pneumococcal Vaccine Win That “Sets a New Benchmark” | 2026-10-05 12:41 | [Source Link](https://news.google.com/rss/articles/CBMipwFBVV95cUxNcXl2TGQ4R3lMTF9PazY2NlEzQnRGLU1YU0Z4clNXMFZfWnhCWi15c0owZ0MwTEFXT05LeE9KdU1oSkc3QTN6MDdEZVoxLWpjdEpIWDRKRC1KMjRxcDVaUGgwQUY1ZXcyNHgtdWF0bUdhT0JNVVFHTkJfblQtLVl2SEQ1RnFaNEpDWjdXd25CSTRXelVFLUZTSjFzbXFJOEpFdEMzOHFQUQ?oc=5) |
| statnews.com | Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market | 2026-10-05 12:41 | [Source Link](https://news.google.com/rss/articles/CBMijAFBVV95cUxOeEQwUzl0VVhjQjkzdmUyRFA1b0lTb0xWY2FmdVBvdThTMWFJYy1fV2hOYXF3RU5pR3hWbHFUb1VWUjdXd0xLd0R6NG5RMEtsYjZrMml4cy1mNHdyOVo3cVlnQ0JvQUhSMjVXUUxBbmJTRlRTTDMwTVgxd3BXZGF3UlVYX2N2VGVyZ0xvSw?oc=5) |
| Barron's | Vaxcyte Stock Spikes 27% as Lead Vaccine Candidate Takes Aim at Pfizer and Merck | 2026-10-05 12:41 | [Source Link](https://news.google.com/rss/articles/CBMiggFBVV95cUxQMU8yUzk3OVpkcEpCRXk0OHd3bmRIR1B3LVMzUnE3TW1mT252d2dCOU85TXJJdXRUSFBqckRnNXgwdlVOMEloVFkyTU9NdDBZWkhkN0ExTWVZcWpoYkQzSVBZcjZmb3VLQ3VZalN5R1dMMWZmS3ZlVkQyQUxZdEk2RjZB?oc=5) |
| Investor's Business Daily | Small Biotech Squares Up To Pfizer, Merck In $7 Billion Market | 2026-10-05 12:41 | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxNNFBEVU83SWZFZ0VNcnM3SFNXZTB1WFF6MEZWN3hVcVZYZkpQUXhIQWFjSWpYM1MwenRiLTJUUW1SNHpUMFlkUkdvVzVtMmxuSHRkN3pGX0JPbnJDZVZYV001NDBKaU1HSjZHRXNzem5yMkJBdjRoaGlNQWlKUlRIdWlhYkxuaXhfbTFnN2FnVEYzUUFv?oc=5) |
| BioPharma Dive | Vaxcyte skyrockets on ‘near best-case’ pneumococcal vaccine data | 2026-10-05 12:41 | [Source Link](https://news.google.com/rss/articles/CBMirAFBVV95cUxQZ0xOTUJSV0V1TlpUOExXZzBNanI4WnlSUVNZSE44M2JtMDNoYzBORzN0MEJUSGY4OENxTGtTNWdxbldfWVJLaXc2aTdKRWlYeEUzR0ZLN2sxS21tdzBzZTh1NU9LelBzb0YxMHN0SFhvNXh4YjJTbUlRTENDbkJUV2tBTHRhaHQzSDB2bWtEd0pmQVVVNVdBZUdwaDBvbm5NYlBqbG9sejBWMllR?oc=5) |
| fiercebiotech.com | Vaxcyte’s stock jumps as pneumococcal vaccine holds its own against Pfizer's, Merck’s shots | 2026-10-05 12:41 | [Source Link](https://news.google.com/rss/articles/CBMivgFBVV95cUxQVV83V2NkTUQ0a3dMTHF1bXVUMkM4OWdMcEd6U3pvVDd4Y25heDlWNUJjX2ItXzZ1X3BMMDdPR2JFLUNOODFxRS0ySFhXQ0lwNWJyamRJRGNad1RnRXl4eHlZd25mMEhlVFRSUzFwZFh4RVNkTXQ2eTNBeFRhZ3d1WldhdTAyNGhlN0M0bC1NWlpOMDZPdER6dldRQi0xNm5UY09FRG9XeDl4cGIzUkxTXzBfdmxXR2ZYUVRzUzR3?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-10-05/vaxcyte-s-stock-jumps-as-pneumococcal-vaccine-holds-its-own-against-pfizer-s*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*